Characteristics and outcomes of patients undergoing paraesophageal hernia repair with selective use of biologic mesh
Sign Up to like & getrecommendations! Published in 2021 at "Surgical Endoscopy"
DOI: 10.1007/s00464-021-08399-w
Abstract: The use of biologic mesh in paraesophageal hernia repair (PEHR) has been associated with decreased short-term recurrence but no statistically significant difference in long-term recurrence. Because of this, we transitioned from routine to selective use… read more here.
Keywords: use biologic; biologic mesh; recurrence; repair ... See more keywords
2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs in patients with rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.13130
Abstract: In June 2015, the Thai Rheumatism Association (TRA) approved an update of its recommendation for the use of biologic disease‐modifying anti‐rheumatic drugs (bDMARDs) and targeted synthetic (tsDMARD) in the treatment of rheumatoid arthritis (RA) to… read more here.
Keywords: use biologic; rheumatism association; thai rheumatism; modifying anti ... See more keywords
The use of biologic agents in the management of uveitis
Sign Up to like & getrecommendations! Published in 2018 at "Internal Medicine Journal"
DOI: 10.1111/imj.14215
Abstract: The uveitides are a heterogenous group of ocular inflammatory disorders that account for the third highest cause of blindness worldwide, responsible for 5–10% of visual impairment globally. Up to 35% of patients with uveitis can… read more here.
Keywords: use biologic; medicine; agents management; biologic agents ... See more keywords